ENST00000438158 aids ultrasound for predicting lymph node metastasis and inhibits migration and invasion of papillary thyroid carcinoma cells

被引:1
作者
Liu, Hui [1 ]
Shi, Yixin [1 ]
Zhan, Jia [1 ]
Liu, Yingchun [1 ]
Zhou, Jing [2 ,3 ,4 ]
Su, Biao [1 ]
Chen, Yue [1 ]
Wang, Ling [2 ,3 ,4 ]
Chen, Lin [1 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Ultrasound, 211 West Yanan Rd, Shanghai 200040, Peoples R China
[2] Hosp Fudan Univ, Lab Reprod Immunol Obstet & Gynecol, 419 Fangxie Rd, Shanghai 200011, Peoples R China
[3] Fudan Univ, Acad Integrat Med, Shanghai, Peoples R China
[4] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
关键词
Ultrasound; papillary thyroid carcinoma; ENST00000438158; cervical lymph node metastasis; LONG NONCODING RNAS; FINE-NEEDLE-ASPIRATION; THYROGLOBULIN MEASUREMENT; DIAGNOSTIC PERFORMANCE; CANCER INCIDENCE; PROLIFERATION; ELASTOGRAPHY; METAANALYSIS; EXPRESSION; MANAGEMENT;
D O I
10.5582/ddt.2022.01061
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cervical lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC) is directly associated with clinical management and prognosis. In this study, we aimed to evaluate the value of conventional ultrasound (US) combined with ENST00000438158 in predicting CLNM of PTC. Fourty-nine PTC patients underwent US examination and US-guided fine needle aspiration (FNA). ENST00000438158 expression in FNA cytological specimens and PTC cell lines was detected using real-time reverse transcription polymerase chain reaction (qRT-PCR). The role of ENST00000438158 expression in the proliferation, migration, invasion, apoptosis, and cell cycle of PTC cells was investigated by Cell Counting Kit-8 (CCK8) and clone formation experiments, transwell assay, and flow cytometry, respectively. Calcification, capsule contact, and low ENST00000438158 expression were independently associated with PTC with CLNM (all p < 0.05). The combination of multiple US features was more valuable than a single US feature in predicting CLNM in PTC. Adding ENST0000438158 to US greatly improved the value of differentiation of PTC with or without CLNM. In conclusion, ENST00000438158 is a potential molecular marker for predicting CLNM in PTC. ENST00000438158 combined with US features is highly valuable for predicting CLNM in PTC.
引用
收藏
页码:26 / 36
页数:11
相关论文
共 51 条
[1]  
Al-Brahim N, 2006, ARCH PATHOL LAB MED, V130, P1057
[2]   Clinical Risk Factors Associated with Cervical Lymph Node Recurrence in Papillary Thyroid Carcinoma [J].
Baek, Seung-Kuk ;
Jung, Kwang-Yoon ;
Kang, Sun-Mook ;
Kwon, Soon-Young ;
Woo, Jeong-Soo ;
Cho, Seung-Hyun ;
Chung, Eun-Jae .
THYROID, 2010, 20 (02) :147-152
[3]   Preoperative Staging of Papillary Thyroid Carcinoma: Comparison of Ultrasound Imaging and CT [J].
Choi, Ji Soo ;
Kim, Jinna ;
Kwak, Jin Young ;
Kim, Min Jung ;
Chang, Hang Seok ;
Kim, Eun-Kyung .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (03) :871-878
[4]   Psammoma Body: A Product of Dystrophic Calcification or of a Biologically Active Process That Aims at Limiting the Growth and Spread of Tumor? [J].
Das, Dilip K. .
DIAGNOSTIC CYTOPATHOLOGY, 2009, 37 (07) :534-541
[5]  
Di W, 2017, AM J CANCER RES, V7, P1298
[6]   Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors [J].
Diaz del Arco, Cristina ;
Diaz Perez, J. Angel ;
Ortega Medina, Luis ;
Sastre Valera, Javier ;
Fernandez Acenero, M. Jesus .
ENDOCRINE PATHOLOGY, 2016, 27 (04) :276-283
[7]   Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer [J].
Ding, Jian ;
Wang, Fuqing ;
Xiang, Tiangang ;
Qiao, Meng .
ONCOLOGY RESEARCH, 2018, 26 (07) :1047-1053
[8]   Long Noncoding RNAs in Cell-Fate Programming and Reprogramming [J].
Flynn, Ryan A. ;
Chang, Howard Y. .
CELL STEM CELL, 2014, 14 (06) :752-761
[9]   Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer [J].
Frasoldati, A ;
Toschi, E ;
Zini, M ;
Flora, M ;
Caroggio, A ;
Dotti, C ;
Valcavi, R .
THYROID, 1999, 9 (02) :105-111
[10]  
Frasoldati Andrea, 2004, Endocr Pract, V10, P261